Published On: 4/25/2025

How does causalStudio™ address the key regulatory requirements for data integrity, traceability, and analysis?

Welcome back to Target RWE’s Behind the Data series! In this episode, McKinley Peter, Digital Marketing Specialist at Target RWE, is joined once again by Dr. David Pritchard, Director of Data Management and Statistics, for a deeper dive into causalStudio™—Target RWE’s innovative platform designed to advance real-world data analysis. Building on their last conversation, today’s discussion explores how the integrated tools causalRisk™ and causalPHR™ work together to meet regulatory demands for data integrity and traceability, while also providing flexible, user-friendly solutions for analyzing and visualizing data from diverse sources.

Ready to see how causalStudio™ is transforming real-world evidence generation? Watch the full interview now to discover how causalRisk™ and causalPHR™ work together to deliver regulatory-grade insights with clarity and confidence.

About Target RWE

Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables comprehensive insight generation from complete retrospective and prospective longitudinal patient journeys, with unparalleled scale and accuracy.

Visit our website to learn more: https://targetrwe.com/

Contact:

Kayla Slake
Senior Manager, Marketing

kslake@targetrwe.com

984.234.0268 ext 205

More News

READ MORE